Hepato p ancreaticobiliary R esection Arginine I mmuno m odulation (PRIMe) trial: protocol for a randomised phase II trial of the impact of perioperative immunomodulation on immune function following resection for hepatopancreaticobiliary malignancy.

Ramy BehmanRebecca C AuerLev BubisGrace XuNatalie G CoburnGuillaume MartelJulie HalletFady BalaaCalvin LawKimberly A BertensJad Abou KhalilPaul Jack Karanicolas

Published in: BMJ open (2024)

ClinicalTrials.gov identifier: NCT04549662.

Keyphrases

open label
phase iii
study protocol
phase ii
clinical trial
placebo controlled
randomized controlled trial
double blind
nitric oxide
cardiac surgery
patients undergoing
amino acid